Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Neurourol Urodyn. 2015 Sep 1;35(8):1017–1023. doi: 10.1002/nau.22872

Table 1.

Clinical characteristics

OAB Controls
No. of subjects 51 30
Age (mean ± SD) 53.4 ± 11.9 54.2 ± 12.3
Sex (% females) 73% 57%
Age of diagnosis of
OAB (mean ± SD)
47.5 ± 15.2 NA
% with OAB
symptoms less than
one year? (recent
onset cases)
24% NA
Comorbidities:
 Hypertension 37% 33%
 Diabetes 8% 3%
 Stroke, TIA 8% 7%
 Angina, MI 0% 0%
 Depression 32% 17%
 Anxiety 20% 7%
Symptom indexes:
(mean ± SD)
ICIQ-UI (urinary
incontinence, 0-21)
12.0 ± 4.9 1.4 ± 2.0
ICIQ-OAB
(overactive bladder,
0-16)
9.3 ± 2.6 2.0 ± 1.5
OAB-q symptom
bother subscale (6-
36)
19.1 ± 6.6 2.2 ± 2.8
OAB-q quality of life
subscale (13-78)
29.7 ± 16.9 2.0 ± 3.0
UDI-6 (urogenital
distress inventory,
0-24)
12.6 ± 5.6 0.9 ± 1.4
IIQ-7 (incontinence
impact
questionnaire, 0-28)
8.8 ± 8.2 0.1 ± 0.4
USS (urgency
severity scale, 0-3)
2.1 ± 0.7 0.5 ± 0.6
Numeric rating
scale of urgency
(0-10)
6.1 ± 2.6 0.4 ± 0.6
Numeric rating
scale of frequency
(0-10)
6.4 ± 2.6 0.6 ± 0.9